Scienture Holdings Statistics
Total Valuation
SCNX has a market cap or net worth of $16.05 million. The enterprise value is $9.41 million.
Important Dates
The next estimated earnings date is Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SCNX has 40.63 million shares outstanding. The number of shares has increased by 354.69% in one year.
| Current Share Class | 40.63M |
| Shares Outstanding | 40.63M |
| Shares Change (YoY) | +354.69% |
| Shares Change (QoQ) | -1.99% |
| Owned by Insiders (%) | 19.29% |
| Owned by Institutions (%) | 6.36% |
| Float | 32.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 37.18 |
| Forward PS | n/a |
| PB Ratio | 0.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 21.81 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.00.
| Current Ratio | 2.89 |
| Quick Ratio | 2.70 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.98 |
Financial Efficiency
Return on equity (ROE) is -55.65% and return on invested capital (ROIC) is -13.29%.
| Return on Equity (ROE) | -55.65% |
| Return on Assets (ROA) | -10.74% |
| Return on Invested Capital (ROIC) | -13.29% |
| Return on Capital Employed (ROCE) | -19.95% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $47,957 |
| Profits Per Employee | -$4.61M |
| Employee Count | 9 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.99M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.27% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -56.27% |
| 50-Day Moving Average | 0.41 |
| 200-Day Moving Average | 0.83 |
| Relative Strength Index (RSI) | 52.50 |
| Average Volume (20 Days) | 808,963 |
Short Selling Information
The latest short interest is 2.22 million, so 5.47% of the outstanding shares have been sold short.
| Short Interest | 2.22M |
| Short Previous Month | 2.99M |
| Short % of Shares Out | 5.47% |
| Short % of Float | 6.78% |
| Short Ratio (days to cover) | 0.29 |
Income Statement
In the last 12 months, SCNX had revenue of $431,609 and -$41.51 million in losses. Loss per share was -$2.70.
| Revenue | 431,609 |
| Gross Profit | 331,482 |
| Operating Income | -16.24M |
| Pretax Income | -43.51M |
| Net Income | -41.51M |
| EBITDA | -15.79M |
| EBIT | -16.24M |
| Loss Per Share | -$2.70 |
Full Income Statement Balance Sheet
The company has $6.66 million in cash and $24,137 in debt, with a net cash position of $6.64 million or $0.16 per share.
| Cash & Cash Equivalents | 6.66M |
| Total Debt | 24,137 |
| Net Cash | 6.64M |
| Net Cash Per Share | $0.16 |
| Equity (Book Value) | 70.12M |
| Book Value Per Share | 1.73 |
| Working Capital | 5.18M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -13.38M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 455,846 |
| Net Borrowing | -6.16M |
| Free Cash Flow | -13.38M |
| FCF Per Share | -$0.33 |
Full Cash Flow Statement Margins
| Gross Margin | 76.80% |
| Operating Margin | -3,763.78% |
| Pretax Margin | -10,080.22% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SCNX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -354.69% |
| Shareholder Yield | -354.69% |
| Earnings Yield | -258.66% |
| FCF Yield | -83.37% |
Analyst Forecast
The average price target for SCNX is $1.50, which is 279.75% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $1.50 |
| Price Target Difference | 279.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 175.89% |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SCNX has an Altman Z-Score of -0.97 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.97 |
| Piotroski F-Score | 4 |